Infectious Disorders - Drug Targets

Scopus Cite Score: 3.3

Indexed in: Scopus, MEDLINE/PubMed, Cabell's Directory/Journalytics

View All

Aims and Scope: Infectious Disorders - Drug Targets aims to cover all the latest and outstanding developments in medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in infectious disorders, e.g. disease disease-specific proteins, receptors, enzymes and genes. Each issue of the journal contains a series of timely, in-depth reviews/mini-reviews and research articles written by leaders in the field, covering a range of current topics on drug targets involved in infectious disorders. As the discovery, identification, characterization and validation of novel drug targets for anti-infective drug discovery continue to grow, this journal will be essential reading for all pharmaceutical scientists involved in drug design, discovery and development. All aspects of the epidemiology, pathogenesis, clinical relevance, theranostics, as well as preventive measures related to infectious disorders caused by bacteria, fungi, parasites, viruses, HIV and other sexually transmitted diseases (STDs) are also included in the scope of the journal.

Infectious Disorders - Drug Targets is an international, peer-reviewed journal on all aspects of drug targets involved in infectious disorders, published bi-monthly (print & online) by Bentham Science Publishers.

Read more...

Editor-in-Chiefcasc:

  • Veeranoot Nissapatorn School of Allied Health Sciences
    Research Excellence Center for Innovation and Health Products (RECIHP)
    Walailak University
    Nakhon Si Thammarat
    Thailand

ISSN: 1871-5265 (Print)

eISSN: 2212-3989 (Online)

Special Issues With Active Call for Papers

Submission closes on: Jul 16, 2026
Emerging Mechanisms and Novel Drug Targets in Infectious Diseases: From Pathogenesis to Precision Therapeutics

The ongoing global burden of infectious diseases is compounded by the rapid emergence of antimicrobial resistance (AMR), novel pathogens such as SARS-CoV-2 variants and drug-resistant mycobacterium tuberculosis, and the resurgence of neglected tropical diseases. These challenges underscore the urgent need for innovative approaches in drug discovery and translational research. The complexity of host-pathogen interactions, coupled with the ability of pathogens to evolve and evade therapeutic interventions, highlights critical gaps in our understanding of disease mechanisms... see more

Submission closes on: Dec 31, 2025
New Frontiers in Infectious Disease Research: Small-Molecule Probes and Biomarker Identification

The biological relevance of small-molecule chemical probes targeting a disease model is crucial in the early stages of drug discovery. The integration of omics technologies such as genomics, proteomics, metabolomics, immunomic, and cellular levels has greatly enhanced the ability to identify novel biomarkers and understand the complex interactions between pathogens and their hosts. However, due to rapid advancements in omics technologies, the criteria for selectivity, biochemical and cellular activities for molecular probes are constantly evolving... see more